Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese

Pharmacogenomics Ahead of Print.

Source: Future Medicine: Pharmacogenomics - December 4, 2016 Category: Genetics & Stem Cells Authors: Xi Li Jun Zhang Xi Wu Han Yan Yin Zhang Ruo-Hui He Yong-Jun Tang Yi-Jing He Dan Tan Xiao-Yuan Mao Ji-Ye Yin Zhao-Qian Liu Hong-Hao Zhou Jie Liu Source Type: research